Potassium Citrate ER (Potassium Citrate) Patent Expiration, LOE Window & CMS Spending

Potassium Citrate ER (Potassium Citrate) by Ut Southwestern Medctr: Off-Patent Genericized (AB Competition), 8 AB generics, $53.2M 2024 CMS Part D & Medicaid spend, and $1,863 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorUt Southwestern Medctr
FDA Application & PathwayN019647 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors8
2024 CMS Total Public Spend$53.2M
2024 Medicare Part D Spend$49.9M
2024 Medicaid Spend$3.3M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,863 intro WAC)